Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
5.74
+0.22 (3.99%)
At close: Mar 10, 2026, 4:00 PM EDT
5.71
-0.03 (-0.52%)
Pre-market: Mar 11, 2026, 8:00 AM EDT
Cybin Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
50
Market Cap
287.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | 686.88K | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cellectis | 82.55M |
| Coherus Oncology | 42.17M |
| OmniAb | 18.67M |
| Ovid Therapeutics | 6.61M |
| AC Immune | 5.48M |
| Orchestra BioMed Holdings | 2.82M |
| Silence Therapeutics | 559.00K |
| Abeona Therapeutics | 400.00K |
HELP News
- 4 days ago - Cybin Inc. (HELP) Discusses Phase II Results for HLP004 in Generalized Anxiety Disorder Prepared Remarks Transcript - Seeking Alpha
- 5 days ago - Helus Pharma Stock Tumbles As Anxiety Drug Study Disappoints - Benzinga
- 5 days ago - Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder - GlobeNewsWire
- 14 days ago - HELUS Pharma: Transitioning From Psychedelic Research To Late-Stage Clinical Neuroscience - Seeking Alpha
- 14 days ago - Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee - GlobeNewsWire
- 21 days ago - Nature Medicine Publishes Helus Pharma's Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder - GlobeNewsWire
- 25 days ago - HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Cybin Initiates At-The-Market Equity Program of up to US$100 Million - Business Wire